---

---

symbols : GLAXF   

save search

---

Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 4.25% | O: -12.81% H: 8.43% C: 5.21%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 6.68% | O: -8.67% H: 2.89% C: 2.14%
FULC | $7.275 -2.22% -2.27% 350K |

Health Technology

| -6.19% | O: -10.82% H: 17.27% C: 9.39%
therapeutics update results

---

Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -1.34% | O: 5.22% H: 0.0% C: -1.25%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -7.68% | O: 2.13% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -2.41% | O: 0.14% H: 0.0% C: 0.0%
VIR | $8.04 -1.11% -1.12% 770K |

Health Technology

| -81.02% | O: -6.42% H: 8.6% C: 8.45%
SRNE | $0.015 -8.85% 56K |

Health Technology

| -99.8% | O: 6.57% H: 14.77% C: 11.21%
RDHL | $0.415 -2.99% -3.08% 190K |

Health Technology

| -84.39% | O: 0.37% H: 10.37% C: 9.63%
covid vaccine

---

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 12:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -7.63% | O: -1.77% H: 0.0% C: -3.55%
CGEM | $18.9 13.38% 11.8% 1.2M |

| 54.2% | O: -2.53% H: 7.62% C: 7.29%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -2.41% | O: 0.6% H: 2.92% C: 2.21%
financial results report results

---

Anti-obesity Drugs Market Size to Grow by USD 454.51 million | Growing Obese Population to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-07-06 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -23.06% | O: -0.73% H: 1.02% C: 1.02%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -24.51% | O: -0.51% H: 0.73% C: 0.07%
BHC | $8.56 0.35% 0.0% 2M |

Health Technology

| -5.41% | O: -0.77% H: 1.61% C: -4.45%
RYTM 4 | $39.71 -0.73% -0.73% 400K |

Health Technology

| 802.5% | O: 0.45% H: 8.37% C: 7.24%
research growing growth market obesity

---

Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 6.43% | O: 0.88% H: 3.85% C: 3.85%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 8.18% | O: -0.24% H: 0.01% C: -0.77%
ZNTL | $11.76 -6.44% -6.89% 850K |

Health Technology

| -35.47% | O: 1.54% H: 8.37% C: 5.89%
treatment preclinical meeting

---

Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 27.65% | O: -0.06% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 12.32% | O: 6.22% H: 3.13% C: -0.56%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 18.54% | O: 2.81% H: 0.43% C: -0.2%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -14.94% | O: 0.18% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 26.03% | O: 2.59% H: 0.72% C: 0.63%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -38.76% | O: 1.22% H: 0.01% C: -1.7%
IOVA 4 | $11.69 -1.43% -1.45% 2.7M |

Health Technology

| 49.36% | O: 6.12% H: 4.99% C: 4.21%
INO | $10.1 -2.6% -2.67% 250K |

Health Technology

| 366.06% | O: 5.5% H: 4.35% C: 3.48%
GILD | $67.07 0.06% 0.06% 8.3M |

Health Technology

| -18.51% | O: 1.43% H: 0.36% C: -1.08%
ATRA | $0.7101 -1.18% -1.2% 700K |

Health Technology

| -81.7% | O: 2.58% H: 23.12% C: 20.85%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 16.63% | O: 7.08% H: 0.84% C: -0.43%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -48.57% | O: 0.0% H: 7.14% C: 5.71%
covid-19 research global immunotherapy report impact technology market

---

$12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners
Published: 2022-10-28 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 12.64% | O: 3.33% H: 0.74% C: -1.67%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 24.88% | O: 0.89% H: 1.3% C: 0.79%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 13.56% | O: 2.57% H: 0.0% C: 0.0%
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| -24.47% | O: -0.88% H: 5.85% C: 5.69%
influenza market vaccine

---

Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -4.84% | O: -0.46% H: 3.49% C: 3.49%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 18.23% | O: 2.25% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K |

Manufacturing

| 17.44% | O: 1.41% H: 2.33% C: 0.04%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -8.7% | O: 2.07% H: 1.62% C: 1.56%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 16.75% | O: 0.74% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -2.01% | O: 0.41% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -29.95% | O: 0.26% H: 0.31% C: -0.39%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -7.77% | O: 0.82% H: 0.0% C: 0.0%
AUPH | $5.03 -1.18% -1.19% 790K |

Health Technology

| -52.05% | O: 0.95% H: 6.23% C: 5.19%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 17.9% | O: 0.41% H: 0.0% C: -0.37%
lupus market

---

Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 7.88% | O: -1.66% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 12.1% | O: -0.03% H: 0.38% C: 0.25%
ZNTL | $11.76 -6.44% -6.89% 850K |

Health Technology

| -48.4% | O: 2.59% H: 4.49% C: 4.23%
pharmaceuticals financial results

---

CureVac veröffentlicht in „Nature” präklinische Daten des COVID-19-Kandidaten der zweiten Generation, CV2CoV, die vergleichbaren Antikörperspiegel wie bei lizenziertem mRNA-Impfstoff nachweisen
Published: 2021-11-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -7.37% | O: -6.25% H: 3.09% C: -0.45%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -3.29% | O: -1.66% H: 0.24% C: -0.12%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -93.21% | O: 8.03% H: 4.75% C: 2.8%
covid cv2cov

---

Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published: 2022-11-04 (Crawled : 18:00) - prnewswire.com
GNMSF | News | $290.34 3.83% 340 |

Health Technology

| -29.52% | O: -2.57% H: 3.43% C: 2.04%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 45.46% | O: 2.28% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 22.36% | O: 1.13% H: 0.63% C: 0.53%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -12.82% | O: 0.38% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 24.42% | O: 1.25% H: 0.03% C: -0.78%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 107.98% | O: 0.97% H: 0.18% C: -2.13%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -37.74% | O: 0.42% H: 0.59% C: -0.04%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 16.19% | O: 0.64% H: 0.16% C: -0.05%
GMAB | News | $28.47 -0.32% -0.32% 460K |

Health Technology

| -27.65% | O: 0.58% H: 0.93% C: 0.93%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 2.68% | O: -1.48% H: 2.81% C: 2.71%
report cancer market

---

Breakthroughs In Treating Killer Diseases Could Lengthen Life
Published: 2022-06-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -27.82% | O: 0.0% H: 0.86% C: 0.84%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 7.76% | O: 4.83% H: 0.0% C: -5.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -16.42% | O: -0.18% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -4.56% | O: 0.37% H: 3.03% C: 2.98%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 139.05% | O: -3.62% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 12.09% | O: 0.54% H: 2.78% C: 2.69%
life disease

---

Global Cancer Immunotherapy Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-04-06 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -9.28% | O: 0.23% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -11.49% | O: 4.21% H: 0.0% C: -0.61%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -1.65% | O: 1.45% H: 0.46% C: 0.19%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 7.8% | O: 1.98% H: 0.0% C: -1.11%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 8.49% | O: 0.39% H: 0.53% C: 0.44%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -17.38% | O: 1.15% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -9.19% | O: 1.01% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 145.95% | O: -0.27% H: 2.95% C: 1.12%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -35.15% | O: 0.05% H: 2.52% C: 2.49%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -11.02% | O: 1.74% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 3.08% | O: 0.35% H: 2.64% C: 2.45%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 9.23% | O: -0.29% H: 1.42% C: 0.98%
immunotherapy cancer market

---

Bronchitis Treatment Market Size to Grow by USD 1.12 bn | Technavio
Published: 2022-03-17 (Crawled : 02:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -7.63% | O: -1.77% H: 0.0% C: -3.55%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -8.74% | O: -1.62% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 11.56% | O: 2.2% H: 3.15% C: 0.06%
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| 11.16% | O: -1.25% H: 4.68% C: 3.7%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 15.9% | O: 0.08% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -2.41% | O: 0.6% H: 2.92% C: 2.21%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -8.51% | O: 0.17% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 15.02% | O: 0.34% H: 2.89% C: 2.51%
treatment

---

Respiratory Inhalers Market is Expected to Escalate at a CAGR of 5.38% and Reach USD 47.83 Billion by 2026, Analyzes DelveInsight
Published: 2022-03-17 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -7.63% | O: -1.77% H: 0.0% C: -3.55%
TFX | $211.17 0.03% 1.34% 200K |

Health Technology

| -38.1% | O: -0.23% H: 2.66% C: 1.97%
SYK | $336.85 0.58% 0.0% 1.5M |

Health Technology

| 30.83% | O: 0.43% H: 2.1% C: 2.1%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 15.9% | O: 0.08% H: 0.0% C: 0.0%
MDT | $80.38 -1.12% 0.0% 5M |

Health Technology

| -25.09% | O: -0.19% H: 0.0% C: 0.0%
PHG | News | $20.97 -0.19% 0.0% 650K |

Health Technology

| -34.69% | O: -2.96% H: 1.35% C: 0.74%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -2.41% | O: 0.6% H: 2.92% C: 2.21%
BDX | $233.83 -0.23% 3.49% 780K |

Health Technology

| -9.84% | O: 0.11% H: 0.0% C: 0.0%
INVA | $15.15 -0.13% -0.13% 420K |

Health Technology

| -18.36% | O: 0.16% H: 3.66% C: 3.6%
respiratory

---

Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| -95.56% | O: 0.0% H: 11.11% C: 2.78%
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 12.08% | O: 1.92% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.45% | O: 0.5% H: 0.16% C: 0.16%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 26.59% | O: 0.0% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 7.22% | O: -1.17% H: 1.09% C: 1.01%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 10.79% | O: -1.41% H: 1.75% C: 0.66%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 1.98% | O: -0.14% H: 2.32% C: 2.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.02% | O: -1.32% H: 0.0% C: 0.0%
ORMP A | $2.375 1.06% 1.05% 41K |

Health Technology

| -71.48% | O: 0.48% H: 4.55% C: 3.47%
endocrine growth market endocrine disorders

---

Human Papillomavirus Vaccine (HPV) Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR: Allied Market Research
Published: 2022-07-21 (Crawled : 13:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -3.03% | O: 6.64% H: 0.0% C: -4.08%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -10.34% | O: -2.38% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 4.19% | O: 0.15% H: 0.0% C: -3.5%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 16.78% | O: 0.09% H: 1.9% C: 1.89%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -13.96% | O: -1.18% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -1.78% | O: 1.3% H: 0.38% C: -0.38%
XBIO | $3.85 7.32% 540 |

Health Technology

| -95.37% | O: 0.41% H: 7.44% C: -2.71%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -6.77% | O: -3.38% H: 0.0% C: 0.0%
INO | $10.1 -2.6% -2.67% 250K |

Health Technology

| 355.61% | O: 0.0% H: 1.35% C: -5.83%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 8.22% | O: -2.75% H: 2.31% C: 2.15%
research vaccine market

---

Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | News | $290.34 3.83% 340 |

Health Technology

| -19.98% | O: 2.93% H: 1.47% C: 1.33%
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -28.6% | O: -0.45% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 27.65% | O: -1.05% H: 0.0% C: -0.99%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 10.42% | O: 0.19% H: 0.59% C: -1.36%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -9.54% | O: 0.89% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -36.16% | O: -3.61% H: 3.02% C: 2.02%
BHC | $8.56 0.35% 0.0% 2M |

Health Technology

| -56.64% | O: -1.67% H: 0.0% C: 0.0%
GMAB | News | $28.47 -0.32% -0.32% 460K |

Health Technology

| -18.82% | O: 1.4% H: 0.82% C: -1.07%
t-cell

---

Global Osteoporosis Drugs Market Report 2022: Anabolic Drug Developments Show High Potential to Reshape Sector
Published: 2022-11-07 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 22.83% | O: -3.13% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 23.86% | O: -3.09% H: 0.72% C: -0.09%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 110.46% | O: 0.17% H: 2.51% C: 1.97%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 1.48% | O: -0.33% H: 3.48% C: 3.31%
drug global report potential market osteoporosis

---

The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published: 2023-03-15 (Crawled : 15:20) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 41.18% | O: 2.62% H: 0.0% C: -3.57%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 19.81% | O: -1.0% H: 1.39% C: 1.02%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 21.17% | O: -0.95% H: 1.05% C: 0.54%
ADCT | $4.78 -3.82% 0.0% 280K |

Health Technology

| 94.31% | O: -0.81% H: 3.48% C: -0.82%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 9.07% | O: -1.09% H: 1.45% C: 1.24%
CTIC | $9.09 0.05% 11M |

Health Technology

| 103.47% | O: 0.67% H: 0.67% C: -2.22%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 18.4% | O: -0.08% H: 2.24% C: 1.95%
global therapeutics market

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---